Home Cart 0 Sign in  
X

[ CAS No. 59782-89-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 59782-89-7
Chemical Structure| 59782-89-7
Chemical Structure| 59782-89-7
Structure of 59782-89-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 59782-89-7 ]

Related Doc. of [ 59782-89-7 ]

Alternatived Products of [ 59782-89-7 ]

Product Details of [ 59782-89-7 ]

CAS No. :59782-89-7 MDL No. :MFCD09037455
Formula : C6H5ClIN Boiling Point : -
Linear Structure Formula :- InChI Key :RKRUYZVVYJIPRA-UHFFFAOYSA-N
M.W : 253.47 Pubchem ID :22602819
Synonyms :

Calculated chemistry of [ 59782-89-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.93
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.13
Log Po/w (XLOGP3) : 2.83
Log Po/w (WLOGP) : 2.65
Log Po/w (MLOGP) : 2.33
Log Po/w (SILICOS-IT) : 3.43
Consensus Log Po/w : 2.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.69
Solubility : 0.052 mg/ml ; 0.000205 mol/l
Class : Soluble
Log S (Ali) : -2.76
Solubility : 0.442 mg/ml ; 0.00174 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.98
Solubility : 0.0264 mg/ml ; 0.000104 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.07

Safety of [ 59782-89-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 59782-89-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 59782-89-7 ]
  • Downstream synthetic route of [ 59782-89-7 ]

[ 59782-89-7 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 59782-89-7 ]
  • [ 544-92-3 ]
  • [ 66909-33-9 ]
Reference: [1] Synthetic Communications, 2006, vol. 36, # 9, p. 1235 - 1245
  • 2
  • [ 540-80-7 ]
  • [ 109-63-7 ]
  • [ 38186-82-2 ]
  • [ 59782-89-7 ]
YieldReaction ConditionsOperation in experiment
83% With Ki; sodium thiosulfate In 1,2-dimethoxyethane; acetonitrile; pentane 19b.
2-Chloro-5-iodo-3-methylpyridine
5-Amino-2-chloro-3-methylpyridine (2.3 g, 16.3 mmol) in DME (9.0 mL) was added dropwise to a solution of boron trifluoride diethyl etherate (3.0 mL, 24.4 mmol) in DME (30.5 mL) at -17° C.
After stirring for 15 min, t-butyl nitrite (442 μL, 3.7 mmol) in DME (30.5 mL) was carefully added to the reaction mixture while maintaining the temperature below -5° C.
After complete addition the temperature was allowed to gradually warm to 5° C. over 1 hr.
The mixture was recooled to -17° C., pentane was added and then decanted.
The solid was triturated with pentane (3*) and Et2 O (3*) and then solvent was removed via positive N2 pressure.
The crude diazonium tetrafluoroborate salt was dissolved in acetonitrile (15 mL) and KI (3.0 g, 17.9 mmol) was added at -10° C.
The reaction was allowed to gradually warm to ambient temperature and stir overnight.
A solution of 10percent sodium thiosulfate was carefully added to the reaction mixture which was then poured over Et2 O and the phases separated.
The organic phase was dried (MgSO4), concentrated and the residue chromatographed (silica gel; EtOAc/hexane, 1:50) to afford a white solid (3.42 g, 83percent): 1 H NMR (CD3 OD, 300 MHz) δ2.34 (s, 3H),), 8.09 (d, J=2.2 Hz, 1H), 8.42 (d, J=2.2 Hz, 1H).
Reference: [1] Patent: US5733912, 1998, A,
  • 3
  • [ 166266-19-9 ]
  • [ 59782-89-7 ]
Reference: [1] Patent: US6372766, 2002, B1,
  • 4
  • [ 59782-89-7 ]
  • [ 887707-21-3 ]
Reference: [1] Synthetic Communications, 2006, vol. 36, # 9, p. 1235 - 1245
[2] Synthetic Communications, 2006, vol. 36, # 9, p. 1235 - 1245
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 59782-89-7 ]

Chlorides

Chemical Structure| 927801-77-2

[ 927801-77-2 ]

1-Chloro-4-iodoisoquinoline

Similarity: 0.84

Chemical Structure| 153034-88-9

[ 153034-88-9 ]

2-Chloro-4-iodo-3-methylpyridine

Similarity: 0.82

Chemical Structure| 550347-54-1

[ 550347-54-1 ]

2-Chloro-5-iodo-4-methylpyridine

Similarity: 0.82

Chemical Structure| 887707-25-7

[ 887707-25-7 ]

2-Chloro-5-iodo-3-(trifluoromethyl)pyridine

Similarity: 0.80

Chemical Structure| 343781-49-7

[ 343781-49-7 ]

2,4-Dichloro-5-iodopyridine

Similarity: 0.75

Related Parent Nucleus of
[ 59782-89-7 ]

Pyridines

Chemical Structure| 153034-88-9

[ 153034-88-9 ]

2-Chloro-4-iodo-3-methylpyridine

Similarity: 0.82

Chemical Structure| 550347-54-1

[ 550347-54-1 ]

2-Chloro-5-iodo-4-methylpyridine

Similarity: 0.82

Chemical Structure| 887707-25-7

[ 887707-25-7 ]

2-Chloro-5-iodo-3-(trifluoromethyl)pyridine

Similarity: 0.80

Chemical Structure| 343781-49-7

[ 343781-49-7 ]

2,4-Dichloro-5-iodopyridine

Similarity: 0.75

Chemical Structure| 72093-11-9

[ 72093-11-9 ]

2-Chloro-3,4-dimethylpyridine

Similarity: 0.74